The rollout has sparked confusion among some full-time city residents
Specifically, the company states that FDA-approved GLP-1/GIP medications for weight loss and type 2 diabetes, including Ozempic, Wegovy, Zepbound, and Mounjaro, "may also be eligible for coverage." The company further states that while they "assist with prior authorizations and prescription submissions," they "do not bill insurance directly." This distinction is important: the compounded GLP-1 program itself is described as a cash-pay arrangement, but the company also facilitates access to FDA-approved branded medications that may have insurance pathways
government and the two leading GLP-1 drugmakers, Eli Lilly and Novo Nordisk, to reduce the costs of these drugs
Like all GLP 1 medicines, it works best when combined with sustainable changes to nutrition, activity, sleep, and eating habits
And this distinction matters